Chemed (NYSE:CHE) CEO Kevin Mcnamara Sells 2,000 Shares

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $539.51, for a total value of $1,079,020.00. Following the completion of the sale, the chief executive officer owned 70,418 shares of the company’s stock, valued at $37,991,215.18. The trade was a 2.76% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Chemed Stock Down 0.3%

Shares of NYSE:CHE opened at $539.13 on Wednesday. The business’s 50 day moving average is $471.15 and its 200 day moving average is $437.76. The stock has a market cap of $7.05 billion, a P/E ratio of 27.08, a price-to-earnings-growth ratio of 2.05 and a beta of 0.51. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $551.68. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. During the same period in the previous year, the company posted $4.27 EPS. Chemed’s revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Sell-side analysts predict that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were paid a $0.60 dividend. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a yield of 0.4%. Chemed’s dividend payout ratio is 12.05%.

Hedge Funds Weigh In On Chemed

Large investors have recently added to or reduced their stakes in the company. BNP Paribas Financial Markets lifted its position in Chemed by 14.5% during the fourth quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock valued at $14,985,000 after acquiring an additional 4,430 shares during the last quarter. Abacus FCF Advisors LLC purchased a new position in Chemed in the fourth quarter worth $5,935,000. TD Asset Management Inc grew its holdings in Chemed by 7.5% in the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after purchasing an additional 22,715 shares during the last quarter. Epoch Investment Partners Inc. increased its position in shares of Chemed by 4.9% during the fourth quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock worth $137,945,000 after purchasing an additional 15,133 shares in the last quarter. Finally, C WorldWide Group Holding A S acquired a new position in shares of Chemed during the fourth quarter worth $2,189,000. 95.85% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CHE has been the topic of a number of research reports. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday. Oppenheimer increased their price objective on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday. Bank of America reissued a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $530.75.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.